Malaria Genetic Surveillance
NCT03384498 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30000
Last updated 2022-03-23
Summary
This study is to determine the prevalence and geographical distribution of antimalarial drug resistance-linked genetic mutations in clinical P. falciparum and/or P.Vivax infection in the Greater Mekong Subregion
Conditions
- Plasmodium Falciparum and Plasmodium Vivax
Sponsors & Collaborators
-
University of Oxford
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2023-01-31
- Completion
- 2023-01-31
Countries
- Cambodia
- Laos
- Vietnam
Study Locations
More Related Trials
-
Evaluating the Efficacy of Artesunate-mefloquine and the Relative Roles of Resistance Genetic Markers
NCT02427360 ·Status: COMPLETED
-
Antimalarial Drug Resistance in Mali
NCT00127998 ·Status: COMPLETED ·Phase: NA
-
A Controlled Human Vivax Malaria Infection Study Through Inoculation of Infected Erythrocytes
NCT05071079 ·Status: RECRUITING ·Phase: NA
-
Genetic Association Mapping of Malaria Resistance in Anopheles Gambiae
NCT00850655 ·Status: COMPLETED
-
Village Malaria Worker Expansion
NCT05045547 ·Status: COMPLETED
-
A Trial on Supervised Primaquine Use in Ethiopia
NCT02793388 ·Status: WITHDRAWN ·Phase: PHASE4
-
Innovation Platform
NCT04558528 ·Status: COMPLETED
-
Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa
NCT02974348 ·Status: COMPLETED ·Phase: PHASE3
-
Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases and Malaria Antibody Kinetic
NCT02708199 ·Status: COMPLETED
-
Mass Screening and Treatment for Reduction of Falciparum Malaria
NCT04093765 ·Status: COMPLETED ·Phase: NA
-
Malaria Vaccine Safety and Immunogenicity Study in Healthy Adults
NCT02992119 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combinations of 2 Anti-malarial Drugs (Asia)
NCT03939104 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a Digital Microscope for Malaria
NCT03512678 ·Status: COMPLETED
-
Targeted Chemo-elimination (TCE) of Malaria
NCT01872702 ·Status: COMPLETED ·Phase: NA
-
Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia
NCT00493363 ·Status: COMPLETED ·Phase: NA
-
Artemisinin Resistance in Cambodia
NCT00479206 ·Status: COMPLETED ·Phase: NA
-
Molecular Surveillance of Artemisinin Resistance Malaria in Myanmar
NCT02792816 ·Status: COMPLETED
-
Study to Compare the Triple ACT AL+AQ With the ACT AL in Cambodia and Vietnam
NCT03355664 ·Status: COMPLETED ·Phase: PHASE3
-
Targeting High Risk Populations With Enhanced Reactive Case Detection in Southern Lao Peoples Democratic Republic
NCT04416945 ·Status: WITHDRAWN ·Phase: NA
-
Molecular Diagnostic Methods for Detection of Plasmodium Knowlesi
NCT03988296 ·Status: COMPLETED
-
A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)
NCT06294912 ·Status: COMPLETED ·Phase: PHASE1
-
Severe Malaria and Anti-malarial Drug Resistance in Cambodia
NCT00341003 ·Status: COMPLETED
-
Efficacy of Focal Primaquine Mass Administration for Eliminating Plasmodium Vivax Malaria in Northern Myanmar
NCT06392152 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
VAC063C: A Study to Assess Repeat Blood-stage P. Falciparum Infection
NCT03906474 ·Status: COMPLETED ·Phase: NA
-
Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia
NCT05879224 ·Status: COMPLETED ·Phase: NA